Beta Bionics, Inc. (BBNX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
BBNX currently has 44.4M outstanding shares. with moderate dilution risk from 11M authorized shares representing 24.8% potential dilution. The company has significantly diluted shareholders by 47.67% over the past 2 years, indicating aggressive capital raising.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| Apr 21, 2026 |
10-Q filing | 44.4M shares outstanding |
44M | 11M |
| Oct 28, 2025 |
10-Q filing | 43.6M shares outstanding |
44M | 11M |
| Jul 29, 2025 |
10-Q filing | 43.4M shares outstanding |
43M | 11M |
| May 06, 2025 |
10-Q filing | 43.4M shares outstanding |
43M | 11M |
| Mar 25, 2025 |
10-K filing | 43.3M shares outstanding |
43M | 11M |
| Jan 28, 2025 |
S-1/A filing: This is an S-1/A filing for the initial public offering of common stock of Beta Bionics, Inc. and a concurrent private placement. |
30M | 11M |
| Jan 23, 2025 |
S-1/A filing: Initial public offering of common stock and concurrent private placement. |
N/A | 8.6M |
| Jan 22, 2025 |
S-1/A filing: Beta Bionics, Inc. is offering 7,500,000 shares of common stock in an initial public offering and has granted the underwriters an option to purchase up to 1,125,000 additional shares from selling stockholders and Wellington Hadley Harbor Aggregator IV, L.P has agreed to purchase $17.0 million in shares of common stock at the IPO price in a concurrent private placement. |
N/A | 2.3M |
| Jan 06, 2025 |
S-1 filing: This is an S-1 filing for the initial public offering of common stock of Beta Bionic, Inc. |
N/A | 0 |